Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic, Immune, or Bone Marrow Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00606216
What this trial is testing

Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Undifferentiated Leukemia+3 more
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Ended earlyNCT01350258
What this trial is testing

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Who this might be right for
Hematologic MalignanciesAcute LeukemiaMyelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 8
Early research (Phase 1)Study completedNCT01684150
What this trial is testing

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+1 more
Epizyme, Inc. 51
Testing effectiveness (Phase 2)Ended earlyNCT03303950
What this trial is testing

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

Who this might be right for
AnemiaASXL1 Gene MutationEZH2 Gene Mutation+7 more
University of Utah 6
Early research (Phase 1)Ended earlyNCT03465540
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaNon-Hodgkins Lymphoma+4 more
Amgen 24
Not applicableStudy completedNCT00435864
What this trial is testing

Natural Killer Index From Hematopoietic Stem Cell Graft

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloblastic LeukemiaChronic Myeloid Leukemia
Nantes University Hospital 92
Testing effectiveness (Phase 2)Study completedNCT00002833
What this trial is testing

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)UnknownNCT03091933
What this trial is testing

Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

Who this might be right for
Hematologic CancerRelapse LeukemiaRelapsed Adult ALL+6 more
Ciusss de L'Est de l'Île de Montréal 20
Early research (Phase 1)Study completedNCT00692926
What this trial is testing

Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells

Who this might be right for
MDSAnemia, AplasticInborn Errors of Metabolism+2 more
Joanne Kurtzberg, MD 37
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Not applicableEnded earlyNCT00185523
What this trial is testing

Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemiaLeukemia Acute Promyelocytic Leukemia (APL)+4 more
Stanford University 88
Early research (Phase 1)Study completedNCT02083250
What this trial is testing

Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionAllogeneic Hematopoietic Stem Cell Transplantation Recipient+4 more
M.D. Anderson Cancer Center 70
Not applicableEnded earlyNCT00038818
What this trial is testing

CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation

Who this might be right for
Chronic Myelogenous LeukemiaMultiple MyelomaNon Hodgkin's Lymphoma+2 more
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00068718
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant

Who this might be right for
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+3 more
Fred Hutchinson Cancer Center 35
Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Testing effectiveness (Phase 2)Study completedNCT00558675
What this trial is testing

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Who this might be right for
Hematological MalignancyLeukemiaLymphoma+1 more
Mirror Biologics, Inc. 6
Early research (Phase 1)Study completedNCT01159028
What this trial is testing

Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+1 more
Bio-Path Holdings, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT03970096
What this trial is testing

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Fred Hutchinson Cancer Center 120
Not applicableWithdrawnNCT00499668
What this trial is testing

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+5 more
Vanderbilt-Ingram Cancer Center
Next Page